Olema Pharmaceuticals Total Liabilities

Olema Pharmaceuticals (OLMA) currently reports a total liabilities of $50M as of March 2026. That compares with $26M in the prior-year period — up 91.6% year over year. Use the charts on this page to explore Olema Pharmaceuticals's total liabilities history and peer comparisons.

Olema Pharmaceuticals's total liabilities increased from $26M to $50M — a 91.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Olema Pharmaceuticals reported $50M in total liabilities as of March 2026. That compares with $26M in the prior-year period — up 91.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $50M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Olema Pharmaceuticals, and consider following OLMA for alerts when major investors trade the stock.

Olema Pharmaceuticals is classified in the Healthcare sector. On total liabilities, it currently shows $50M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OLMA with unrelated industries.